We are live on ! Find out more
AI

Advent International Portfolio holdings

AUM $4.24B
1-Year Est. Return 4.24%
This Fund
S&P 500
This Quarter Est. Return
+0.16%
1 Year Est. Return
+4.24%
3 Year Est. Return
+15.25%
5 Year Est. Return
-41.72%
10 Year Est. Return
+104.97%
AUM
$4.83B
AUM Growth
-$134M
Cap. Flow
-$116M
Cap. Flow %
-2.4%
Top 10 Hldgs %
91.48%
Holding
26
New
1
Increased
7
Reduced
7
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 61.84%
2 Consumer Discretionary 16.02%
3 Healthcare 11.27%
4 Financials 5.73%
5 Industrials 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWRG icon
26
First Watch Restaurant Group
FWRG
$780M
-5,289,784
Closed -$82.7M

Similar funds

Advent International's Q4 2025 Portfolio in Review

As of Q4 2025, Advent International held 26 positions worth $4.83B, down 2.7% from $4.97B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Advent International's Q4 2025 filing shows 1 new, 7 increased, 7 reduced and 2 closed positions. Its largest new stake was Waystar Holding Corp: 11,059,899 shares worth $362M. The largest sale was CCC Intelligent Solutions, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 62% of assets, down from 66% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Advent International's largest Q4 2025 buy was Waystar Holding Corp: 11,059,899 shares worth $362M.
  • Advent International added most to Blue Owl Capital in Q4 2025, an estimated $18.9M increase.
  • Advent International's biggest Q4 2025 reduction was Carpenter Technology, cutting an estimated $65.2M.
  • Advent International fully exited CCC Intelligent Solutions in Q4 2025, selling an estimated $340M.
  • Advent International's ten largest holdings make up 91% of its $4.83B portfolio in Q4 2025.
  • Advent International opened 1 new position and closed 2 in Q4 2025.
  • Advent International's portfolio value fell 2.7% quarter-over-quarter to $4.83B.

Based on Advent International's 13F filing for Q4 2025, filed 17 Feb 2026.